Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.37 Insider Own1.20% Shs Outstand111.54M Perf Week-6.64%
Market Cap830.97M Forward P/E- EPS next Y-1.36 Insider Trans-19.00% Shs Float100.68M Perf Month-14.56%
Income-144.00M PEG- EPS next Q-0.32 Inst Own75.60% Short Float7.71% Perf Quarter-25.35%
Sales78.80M P/S10.55 EPS this Y-88.90% Inst Trans-4.72% Short Ratio9.14 Perf Half Y-41.20%
Book/sh2.49 P/B2.99 EPS next Y0.70% ROA-30.40% Target Price24.50 Perf Year-62.69%
Cash/sh2.74 P/C2.72 EPS next 5Y- ROE-41.60% 52W Range6.22 - 25.29 Perf YTD-14.86%
Dividend- P/FCF- EPS past 5Y-2.60% ROI-46.30% 52W High-70.54% Beta2.61
Dividend %- Quick Ratio- Sales past 5Y-6.80% Gross Margin74.70% 52W Low19.77% ATR0.42
Employees235 Current Ratio4.80 Sales Q/Q- Oper. Margin- RSI (14)36.80 Volatility4.29% 5.10%
OptionableYes Debt/Eq0.00 EPS Q/Q-91.10% Profit Margin- Rel Volume1.18 Prev Close7.65
ShortableYes LT Debt/Eq0.00 EarningsMay 09 AMC Payout- Avg Volume849.19K Price7.45
Recom1.50 SMA20-5.37% SMA50-17.40% SMA200-38.44% Volume1,000,909 Change-2.61%
Mar-15-19Resumed Jefferies Buy $21
Nov-12-18Reiterated B. Riley FBR Buy $35 → $29
Dec-18-17Initiated B. Riley FBR, Inc. Buy $26
Oct-24-17Initiated Guggenheim Buy $32
Oct-19-17Reiterated H.C. Wainwright Buy $20 → $29
Oct-04-17Reiterated H.C. Wainwright Buy $14 → $20
Aug-16-17Resumed H.C. Wainwright Buy $14
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jun-13-19 09:36AM  Ligand Inks Oncology Drug Discovery Deal With PhoreMost Zacks
Jun-08-19 09:30AM  Why Is Spectrum Pharma (SPPI) Down 14.4% Since Last Earnings Report? Zacks
Jun-02-19 09:02AM  Spectrum Pharmaceuticals Announces Integrated Results from Two Phase 3 ROLONTIS® (eflapegrastim) Trials Being Presented at the ASCO Annual Meeting Business Wire
May-29-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 Global Healthcare Conference on June 5th Business Wire
May-28-19 07:00AM  Spectrum Announces Poziotinib ZENITH20 Trial HER2 Cohort (Cohort 2) Has Reached Enrollment Target Business Wire
May-21-19 01:33AM  Edited Transcript of SPPI earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents +5.97%
May-16-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 20th Annual B. Riley FBR Investor Conference on May 23rd Business Wire
May-10-19 05:55PM  Spectrum Pharmaceuticals, Inc. (SPPI) Q1 2019 Earnings Call Transcript Motley Fool
10:11AM  Spectrum Pharma (SPPI) Q1 Earnings Lag Estimates, Revenues Nil Zacks
05:05AM  Spectrum Pharma: 1Q Earnings Snapshot Associated Press
May-09-19 04:00PM  Spectrum Pharmaceuticals Reports First Quarter 2019 Financial Results and Pipeline Update Business Wire
07:00AM  Spectrum Announces Asset Purchase and License for a Novel Immuno-Oncology Platform including Two Early Stage Assets Business Wire
May-07-19 10:56AM  Is Spectrum Pharmaceuticals, Inc. (SPPI) A Good Stock To Buy? Insider Monkey -6.05%
May-02-19 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2019 Financial Results Conference Call Business Wire
Apr-25-19 10:33AM  Analysts Estimate Spectrum Pharmaceuticals (SPPI) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-09-19 12:07PM  The Spectrum Pharmaceuticals (NASDAQ:SPPI) Share Price Has Gained 66% And Shareholders Are Hoping For More Simply Wall St. -8.06%
Apr-02-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the H.C. Wainwright Global Life Sciences Conference on April 9 Business Wire
Mar-30-19 09:30AM  Why Is Spectrum Pharma (SPPI) Down 1.1% Since Last Earnings Report? Zacks
Mar-25-19 07:10AM  Report: Exploring Fundamental Drivers Behind ON Semiconductor, Pilgrim's Pride, Merck & Co., Healthcare Services Group, Genomic Health, and Spectrum Pharmaceuticals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Mar-18-19 09:22AM  Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down Zacks
Mar-15-19 07:23AM  Spectrum Pharma withdraws license application for Rolontis after FDA seeks information on manufacturing MarketWatch
07:00AM  Spectrum Pharmaceuticals Provides BLA Filing Update for ROLONTIS® (eflapegrastim) Business Wire
Mar-13-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Oppenheimer 29th Annual Healthcare Conference on March 20 Business Wire
Mar-06-19 09:05AM  Ligand Sells Promacta Rights for $827M, Updates '19 View Zacks -6.14%
Mar-05-19 04:09PM  Edited Transcript of SPPI earnings conference call or presentation 28-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-01-19 05:28PM  Spectrum Pharmaceuticals Announces the Completion of the Sale of its Marketed Portfolio Business Wire
09:33AM  Spectrum (SPPI) Misses Earnings Estimates in Q4, Tops Sales Zacks
Feb-28-19 06:30PM  Spectrum Pharmaceuticals Inc (SPPI) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:00PM  Spectrum Pharmaceuticals Reports Fourth Quarter 2018 and Full Year 2018 Financial Results and Pipeline Update Business Wire
Feb-21-19 01:38PM  Read This Before Buying Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Shares Simply Wall St.
07:00AM  Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results Conference Call Business Wire
Feb-07-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum on February 14 Business Wire
12:50AM  Top 4 Small-Cap Stocks for 2018 Investopedia
Jan-17-19 08:25AM  Spectrum Pharma Sells Marketed Portfolio in a Deal That Could Reach $300 Million TheStreet.com
07:56AM  Spectrum Pharma sells marketed portfolio for $160 million upfront, up to $140 million in milestone payments MarketWatch
07:45AM  Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients Business Wire
Jan-03-19 10:29AM  Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study Zacks
Jan-02-19 07:00AM  Spectrum Pharmaceuticals Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations Business Wire +5.49%
Dec-28-18 09:45AM  Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis Zacks
Dec-27-18 04:37PM  Why J.C. Penney, Tesla, and Spectrum Pharmaceuticals Slumped Today Motley Fool -6.53%
02:54PM  Here's Why Spectrum Pharmaceuticals Fell as Much as 13.1% Today Motley Fool
07:00AM  Spectrum Pharmaceuticals Announces Submission of Biologics License Application to the FDA for ROLONTIS® (eflapegrastim) as a Treatment for Chemotherapy-Induced Neutropenia Business Wire
Dec-20-18 04:07PM  Here's Why Spectrum Pharmaceuticals, Inc. Is Getting Beaten Down Today Motley Fool -38.79%
10:52AM  Spectrum Pharma Shares Plunge As FDA Refuses Breakthrough Designation For Lung Cancer Drug Benzinga
07:53AM  The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum Benzinga
07:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and MannKind ACCESSWIRE
Dec-19-18 05:09PM  Stocks making the biggest moves after hours: Tilray, Spectrum Pharmaceuticals and more CNBC
04:28PM  Spectrum Pharma stock tanks after drug fails to get on speedier track MarketWatch
04:00PM  Spectrum Pharmaceuticals Provides Poziotinib Update Business Wire
Dec-18-18 10:43AM  Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): When Will It Breakeven? Simply Wall St.
Dec-12-18 11:41PM  Is Spectrum Pharmaceuticals, Inc. (SPPI) Going to Burn These Hedge Funds? Insider Monkey
Dec-10-18 09:00PM  Here's Why Spectrum Pharmaceuticals Rose 21.5% in November Motley Fool
Dec-08-18 09:30AM  Spectrum Pharma (SPPI) Down 3.7% Since Last Earnings Report: Can It Rebound? Zacks
Dec-06-18 04:18PM  Edited Transcript of SPPI earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
07:00AM  Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS® (eflapegrastim) at the 2018 SABCS Annual Meeting Business Wire
Dec-03-18 08:25AM  Report: Exploring Fundamental Drivers Behind CVS Health, TransCanada, Nektar Therapeutics, LendingTree, Spectrum Pharmaceuticals, and TripAdvisor New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
07:00AM  Spectrum Pharmaceuticals Announces Positive Results from Phase 2 Trial Evaluating Use of Oral Leucovorin to Potentially Mitigate Mucositis in Patients Treated with FOLOTYN® (pralatrexate) Business Wire
Nov-30-18 07:00AM  Spectrum Pharmaceuticals Highlights Three Posters at the 60th Annual Meeting of the American Society of Hematology Business Wire
Nov-13-18 07:00AM  Spectrum Pharmaceuticals Appoints Dr. Jeffrey Vacirca to its Board of Directors Business Wire
Nov-09-18 08:01AM  Spectrum (SPPI) Earnings and Sales Beat Estimates in Q3 Zacks
07:41AM  Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View Zacks
06:55AM  Today's Research Reports on Trending Tickers: Omeros and Spectrum Pharmaceuticals ACCESSWIRE
Nov-08-18 05:15PM  Spectrum Pharmaceuticals (SPPI) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:08PM  Spectrum Pharma: 3Q Earnings Snapshot Associated Press
04:00PM  Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results Business Wire
Nov-07-18 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 London Healthcare Conference on November 14 Business Wire
Nov-01-18 07:00AM  Spectrum Pharmaceuticals Announces Third Quarter 2018 Financial Results Teleconference and Webcast Business Wire +6.97%
Oct-25-18 10:34AM  Spectrum Pharmaceuticals (SPPI) Q3 Earnings Preview: What's Shaping Up? Zacks +6.53%
Oct-24-18 09:20AM  Analysis: Positioning to Benefit within Spectrum Pharmaceuticals, Carnival, Cadence Design, Tandem Diabetes Care, Rigel Pharmaceuticals, and Regeneron Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -10.88%
Oct-23-18 07:00AM  Spectrum Pharmaceuticals Receives FDA Approval of KHAPZORY (levoleucovorin) for injection Business Wire +5.84%
Oct-19-18 08:28AM  The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut Benzinga
Oct-18-18 07:00AM  Spectrum Pharmaceuticals Announces Dr. Francois Lebel as Chief Medical Officer Business Wire -6.30%
Oct-12-18 10:14AM  Options Traders Expect Huge Moves in Spectrum Pharmaceuticals (SPPI) Stock Zacks
Oct-03-18 06:45PM  Top 4 Small-Cap Stocks for 2018 Investopedia
Sep-27-18 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2018 Cantor Global Healthcare Conference on October 2 Business Wire
Sep-24-18 11:40AM  Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients Business Wire -22.66%
Sep-13-18 01:35PM  Is Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) A Financially Strong Company? Simply Wall St.
09:13AM  Spectrum Pharma Includes First-Line NSCLC in Poziotinib Study Zacks
Sep-12-18 07:00AM  Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial Into First-Line Therapy and Doses First Patient Business Wire -5.35%
Sep-07-18 08:57AM  Spectrum Pharmaceuticals (SPPI) Catches Eye: Stock Jumps 5.7% Zacks
Sep-06-18 08:28AM  The Daily Biotech Pulse: Novartis Divestment, Eyepoint's Drug Gets Coverage, Spectrum's Robust Data Benzinga +5.70%
08:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and NovoCure ACCESSWIRE
Sep-05-18 05:21PM  Spectrum Pharmaceuticals Announces Release of Poziotinib Abstract as Part of the IASLC 19th World Conference on Lung Cancer Business Wire
Sep-02-18 09:41AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Aug-31-18 08:44AM  Implied Volatility Surging for Spectrum Pharmaceuticals (SPPI) Stock Options Zacks
08:15AM  Report: Exploring Fundamental Drivers Behind International Bancshares, Morgan Stanley, Equity Residential, Hormel Foods, Spectrum Pharmaceuticals, and Cousins Properties New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-30-18 07:00AM  Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September Business Wire -6.80%
Aug-28-18 09:00AM  AVANT DIAGNOSTICS ADDS TWO ESTEEMED, INTERNATIONALLY RECOGNIZED BOARD MEMBERS AND FILES ITS 2016 10-K IN PREPARATION OF GETTING CURRENT WITH THE SEC GlobeNewswire
Aug-24-18 11:45PM  Edited Transcript of SPPI earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-13-18 08:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and Alnylam Pharmaceuticals ACCESSWIRE
Aug-10-18 12:31PM  Why Spectrum Pharmaceuticals Inc. Is Up Big on Mixed Earnings Motley Fool +10.67%
09:35AM  Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2 Zacks
Aug-09-18 05:20PM  Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:19PM  Spectrum Pharma: 2Q Earnings Snapshot Associated Press
04:00PM  Spectrum Pharmaceuticals Reports Second Quarter 2018 Financial Results and Pipeline Update Business Wire
Aug-02-18 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2018 Financial Results Teleconference and Webcast Business Wire
Jul-27-18 08:00AM  New Research: Key Drivers of Growth for ICU Medical, A. Schulman, Verso, Eli Lilly, Spectrum Pharmaceuticals, and Intuit Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jul-23-18 07:05AM  Complimentary Technical Snapshots on Sorrento Therapeutics and Three More Biotech Stocks ACCESSWIRE
Jun-29-18 07:00AM  Spectrum Pharmaceuticals Presents ADVANCE Phase 3 ROLONTIS® (eflapegrastim) Data at MASCC 2018 and Announces the Phase 3 RECOVER Study Met the Primary Endpoint Business Wire
Jun-27-18 12:03PM  Harry Boxers four momentum stocks breaking out MarketWatch
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company offers KHAPZORY, a novel folate analog and the pharmacologically active levo-isomer of d, and 1-leucovorin; FOLOTYN, a folate analogue metabolic inhibitor for peripheral T-cell lymphoma (PTCL); ZEVALIN injection to treat non-Hodgkin's lymphoma; MARQIBO for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ, a histone deacytelase, or HDAC, inhibitor for the treatment of patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB, a pan-HER inhibitor for non-small cell lung cancer tumors; ROLONTIS for chemotherapy-induced neutropenia; and QAPZOLA for non-muscle invasive bladder cancer. The company sells its drugs through group purchasing organizations, wholesalers, and directly to hospitals and cancer centers in the United States; and through distributors in Europe. It has a strategic partnership with Servier Canada, Inc.; licensing and development agreement with Cell Therapeutics, Inc.; license agreements with Merck & Cie AG, Medac Pharma, Inc., Sloan-Kettering Institute for Cancer Research, SRI International, Southern Research Institute, Medac Pharma, Inc., Cydex Pharmaceuticals, Inc., and Mundipharma International Corporation Limited; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreements with Hanmi Pharmaceutical Co. Ltd and The University of Texas MD Anderson Cancer Center. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Turgeon Joseph W.CEO & PresidentJun 06Sale7.9518,240145,070430,977Jun 10 08:11 PM
MAIDA ANTHONY E IIIDirectorMay 29Option Exercise6.0950,000304,50072,250May 31 09:33 AM
MAIDA ANTHONY E IIIDirectorMay 29Sale7.7542,643330,35529,607May 31 09:33 AM
Krassner Stuart MitchellDirectorMay 28Option Exercise6.0944,929273,618112,873May 29 05:00 PM
Krassner Stuart MitchellDirectorMay 28Sale8.0037,385299,08075,488May 29 05:00 PM
Krassner Stuart MitchellDirectorMay 24Option Exercise6.095,07130,88273,015May 29 05:00 PM
Krassner Stuart MitchellDirectorMay 24Sale7.945,07140,26467,944May 29 05:00 PM
Turgeon Joseph W.CEO & PresidentMay 16Sale8.5322,702193,755449,217May 17 06:13 PM
Riga Thomas JEVP, COO & CCOMay 14Sale8.822,38821,069258,035May 14 05:58 PM
McGahan Keith MSVP and Chief Legal OfficerMay 14Sale8.824584,041139,291May 14 05:50 PM
McGahan Keith MSVP and Chief Legal OfficerApr 11Sale10.672,01821,532139,749Apr 12 06:17 PM
MAIDA ANTHONY E IIIDirectorApr 11Sale10.6710,738114,57422,250Apr 12 06:01 PM
Riga Thomas JEVP, COO & CCOApr 11Sale10.7516,493177,341260,423Apr 12 06:40 PM
McGahan Keith MSVP and Chief Legal OfficerApr 02Sale10.571,81019,126141,767Apr 03 06:48 PM
Riga Thomas JEVP, COO & CCOApr 02Sale10.571,88219,887276,988Apr 03 06:47 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerApr 01Sale10.764,64249,940236,098Apr 01 06:14 PM
Turgeon Joseph W.CEO & PresidentMar 29Sale10.656,30767,170471,919Mar 29 06:50 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 29Sale10.655,97463,623240,740Apr 01 06:14 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 26Sale9.909269,167246,714Mar 27 06:35 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 25Sale9.463,79735,931247,640Mar 25 05:51 PM
Turgeon Joseph W.CEO & PresidentMar 25Sale9.465,31550,296478,226Mar 25 05:50 PM
MAIDA ANTHONY E IIIDirectorMar 21Option Exercise5.055,50027,77538,488Mar 22 07:54 PM
MAIDA ANTHONY E IIIDirectorMar 21Sale10.005,50055,00032,988Mar 22 07:54 PM
MAIDA ANTHONY E IIIDirectorFeb 21Option Exercise5.055,50027,77538,488Feb 22 04:31 PM
MAIDA ANTHONY E IIIDirectorFeb 21Sale11.635,50063,96532,988Feb 22 04:31 PM
Riga Thomas JEVP, COO & CCOFeb 20Sale11.472,28526,218278,808Feb 20 05:38 PM
McGahan Keith MSVP and Chief Legal OfficerFeb 07Sale11.032,49627,541103,577Feb 08 05:28 PM
MAIDA ANTHONY E IIIDirectorJan 24Option Exercise4.817,25034,86138,688Jan 25 09:27 PM
MAIDA ANTHONY E IIIDirectorJan 24Sale10.377,25075,18332,988Jan 25 09:27 PM
Vyas DolatraiDirectorJan 22Sale10.626,01063,82641,069Jan 24 08:05 PM
Turgeon Joseph W.CEO & PresidentJan 16Sale10.445,09153,135408,541Jan 18 06:02 PM
Riga Thomas JEVP, COO & CCOJan 16Sale10.4410,499109,578231,083Jan 18 06:02 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 16Sale10.443,20733,471216,896Jan 18 05:59 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 11Sale10.8733,692366,333220,103Jan 11 06:27 PM
Turgeon Joseph W.CEO & PresidentJan 11Sale10.8736,311394,810413,632Jan 11 06:44 PM
MAIDA ANTHONY E IIIDirectorJan 07Option Exercise3.927,25028,42040,238Jan 08 05:56 PM
MAIDA ANTHONY E IIIDirectorJan 07Sale10.007,25072,50032,988Jan 08 05:56 PM
MAIDA ANTHONY E IIIDirectorDec 06Option Exercise3.927,25028,42040,238Dec 07 05:26 PM
MAIDA ANTHONY E IIIDirectorDec 06Sale12.607,25091,35032,988Dec 07 05:26 PM
MAIDA ANTHONY E IIIDirectorNov 08Option Exercise3.927,25028,42040,238Nov 09 06:50 PM
MAIDA ANTHONY E IIIDirectorNov 08Sale13.077,25094,75832,988Nov 09 06:50 PM
Gagnon GillesDirectorOct 09Sale15.3310,000153,34972,500Oct 11 08:06 PM
McGahan Keith MSVP and Chief Legal OfficerAug 08Sale20.964379,160105,993Aug 09 05:00 PM
Riga Thomas JEVP, COO & CCOJun 25Sale18.762354,408240,263Jun 26 01:31 PM